SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 16, 16:00
100.45
-1.55 (-1.52%)
VOLUME 111,005
LIVE
NSE
Jan 16, 15:59
100.30
-1.65 (-1.62%)
VOLUME 301,954
Announcements on Vivimed Labs

12th-Jan-2017 20:52Source: BSE

Vivimed Labs- Outcome of Board Meeting

Vivimed Labs Ltd has informed BSE about Outcome of Board Meeting held on January 12, 2017.

12th-Jan-2017 16:54Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on January 12, 2017.

10th-Jan-2017 17:36Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vithal Varalwar

10th-Jan-2017 16:29Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Vyapar Ltd

9th-Jan-2017 17:00Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Vyapar Ltd

9th-Jan-2017 13:28Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding Update on Scheme of Amalgamation of Creative Health Care Private Limited, Octtantis Nobel Labs Private Limited, Klar Sehen Private Limited, Viv...

9th-Jan-2017 13:12Source: BSE

Vivimed Labs- Updates on Scheme of Amalgamation

Vivimed Labs Ltd has informed BSE that the Company has received the certified true copy of the Order of the Honíble Karnataka High Court and Honíble Bombay High Court sanctioning the Scheme of Amalgam...

4th-Jan-2017 09:24Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NYLIM Jacob Ballas India Fund III, LLC

17th-Dec-2016 18:49Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manohar Rao Varalwar

29th-Nov-2016 19:32Source: BSE

Vivimed Labs- Vivimedís FDF facility in Alathur completed successful USFDA inspection

Vivimed Labs Ltd has informed BSE regarding "Vivimedís FDF facility in Alathur completed successful USFDA inspection".

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.